Treace Medical Concepts, Inc.: cashflow_investing
| Value | {"amount": -7816000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-03-31 |
| Status | current |
| Entity | Treace Medical Concepts, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:46:03.089513+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/dbe6cc88-c26b-4378-ad1d-3c4566c9cc28
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-26-213322Retrieved: 2026-08-19T16:46:03.089513+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001630627/cashflow-investing/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/dbe6cc88-c26b-4378-ad1d-3c4566c9cc28
History
- no predecessors — first report